These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 4572453

  • 1. Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis.
    Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Buselmeier TJ, Najarian JS.
    Surgery; 1973 May; 73(5):759-65. PubMed ID: 4572453
    [No Abstract] [Full Text] [Related]

  • 2. Steroid diabetes after renal transplantation--a preliminary report.
    Gunnarsson R, Arner P, Lundgren G, Magnusson G, Ostman J, Groth CG.
    Scand J Urol Nephrol Suppl; 1977 May; (42):191-4. PubMed ID: 356208
    [Abstract] [Full Text] [Related]

  • 3. Hyperosmolar nonketotic syndrome and steroid diabetes. Occurrence after renal transplantation.
    Woods JE, Zincke H, Palumbo PJ, Johnson WJ, Anderson CF, Frohnert PP, Service FJ.
    JAMA; 1975 Mar 24; 231(12):1261-3. PubMed ID: 1090764
    [Abstract] [Full Text] [Related]

  • 4. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 24; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 5. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
    Davisson NA, Westervelt FB, Bolton WK.
    Proc Clin Dial Transplant Forum; 1980 Oct 24; 10():150-4. PubMed ID: 7050977
    [Abstract] [Full Text] [Related]

  • 6. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL, Scruggs BF, Brennan A.
    Clin Nephrol; 1978 Sep 24; 10(3):87-9. PubMed ID: 359210
    [Abstract] [Full Text] [Related]

  • 7. Minimum steroid requirements in the late post-transplant period.
    Turcotte JG, Dickerman RM, Harper ML.
    Transplant Proc; 1975 Mar 24; 7(1):83-8. PubMed ID: 1091049
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.
    Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG.
    Clin Nephrol; 1976 Mar 24; 5(3):123-7. PubMed ID: 770034
    [Abstract] [Full Text] [Related]

  • 9. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
    Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA.
    Clin J Am Soc Nephrol; 2007 May 24; 2(3):517-23. PubMed ID: 17699459
    [Abstract] [Full Text] [Related]

  • 10. Steroid-related complications in the cyclosporine era.
    Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ.
    Clin Transplant; 1994 Jun 24; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant diabetes mellitus and methylprednisolone pharmacokinetics in African-American and Caucasian renal transplant recipients.
    Tornatore KM, Biocevich DM, Reed KA, Tousley K, Gray V, Singh JP, Murray BM, Venuto RC.
    Clin Transplant; 1995 Aug 24; 9(4):289-96. PubMed ID: 7579735
    [Abstract] [Full Text] [Related]

  • 12. Steroid schedule and survival after transplantation.
    Siegel RR, Mazey RM, Curtis JJ, Lucas BA, Luke RG.
    Proc Clin Dial Transplant Forum; 1975 Nov 24; 5():40-6. PubMed ID: 785461
    [No Abstract] [Full Text] [Related]

  • 13. Pretransplant factors and transplant proteinuria in the prognosis of human kidney transplantation. A clinical study of 150 consecutive kidney graft recipients.
    Olander R.
    Scand J Urol Nephrol; 1972 Nov 24; 16():Suppl 16:1-44. PubMed ID: 4631935
    [No Abstract] [Full Text] [Related]

  • 14. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection.
    Oettl T, Zuliani E, Gaspert A, Hopfer H, Dickenmann M, Fehr T.
    Transplantation; 2010 Mar 27; 89(6):702-6. PubMed ID: 20010328
    [Abstract] [Full Text] [Related]

  • 15. Experience in human renal allotransplantation.
    Woods JE, DeWeerd JH, Johnson WJ, Anderson CF, Shorter RG.
    Surg Gynecol Obstet; 1972 Mar 27; 134(3):394-8. PubMed ID: 4551193
    [No Abstract] [Full Text] [Related]

  • 16. Glucocorticoids and avascular bone necrosis in renal transplantation.
    Feletti C, Di Felice A, Scolari MP, Bonomini V.
    Adv Exp Med Biol; 1984 Mar 27; 171():361-8. PubMed ID: 6372399
    [No Abstract] [Full Text] [Related]

  • 17. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine.
    Pelletier RP, Akin B, Ferguson RM.
    Clin Transplant; 2006 Mar 27; 20(1):10-8. PubMed ID: 16556147
    [Abstract] [Full Text] [Related]

  • 18. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar 27; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 19. Memory functions in prednisone-treated kidney transplant patients.
    Bermond B, Surachno S, Lok A, ten Berge IJ, Plasmans B, Kox C, Schuller E, Schellekens PT, Hamel R.
    Clin Transplant; 2005 Aug 27; 19(4):512-7. PubMed ID: 16008597
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients.
    Siraj ES, Abacan C, Chinnappa P, Wojtowicz J, Braun W.
    Transplant Proc; 2010 Jun 27; 42(5):1685-9. PubMed ID: 20620501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.